Enjoy complimentary customisation on priority with our Enterprise License!
The global proteomics market size is estimated to grow by USD 34.00 billion, at a CAGR of 16.83% between 2023 and 2028. Proteomics research is rapidly advancing with a surge in precision techniques and automation. These innovations are revolutionizing the field by enhancing our understanding of protein functions and interactions. Precision proteomics allows for detailed analysis at the molecular level, offering insights into disease mechanisms and potential therapeutic targets. The emergence of sophisticated technologies enables researchers to analyze large datasets more efficiently and accurately than ever before. Moreover, automation streamlines workflows, reducing time and labor costs while increasing throughput and reproducibility. These developments signify a transformative era in proteomics, promising breakthroughs in personalized medicine and biomedical research. As the pace of discovery accelerates, proteomics continues to play a pivotal role in unraveling the complexities of biological systems. It also includes an in-depth analysis of drivers, trends, and challenges. Our market growth and forecasting report examines historic data from 2018 - 2022 , besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Agilent Technologies Inc., Applied Biomics Inc., Bio Rad Laboratories Inc., Biognosys AG, Bruker Corp., Cell Signaling Technology Inc., CellCarta Biosciences Inc., Creative Proteomics, DiaSorin Spa, F. Hoffmann La Roche Ltd., Geno Technology Inc., HORIBA Ltd., Illumina Inc., Merck KGaA, Olink Holding AB, Perkin Elmer Inc., Promega Corp., QIAGEN NV, and Waters Corp.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the reagents segment will be significant during the forecast period. Some examples of reagents used in proteomics include antibodies, buffers and solutions, enzymes, kits, and beads and columns. It enables the identification of disease biomarkers, personalized treatments, and therapy response monitoring. Clinical applications include cancer diagnosis, cardiovascular disease management, infectious disease detection, neurological disease monitoring, and autoimmune disease management.
Get a glance at the market contribution of various segments Download PDF Sample
The reagents segment was valued at USD 9.19 billion in 2018. Regents are used for protein purification and isolation based on specific properties, such as size, charge, or affinity. Key factors, such as high availability, low price, and the generation of fast and reproducible results, are expected to drive the demand for reagents from researchers during the forecast period. This, in turn, drives the growth of the reagents segment of the market.
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The growth of the market in North America is attributed to factors such as the presence of a large biotechnology industry. The increasing funding for proteomics research, the rising focus on personalized medicine, and the growing prevalence of chronic diseases are also driving the growth of the regional market. The US is the largest contributor to market growth in North America due to the high concentration of major players and the presence of well-established healthcare infrastructure. The region is also witnessing significant investments in protein research by asset management firms with strong financials. Extensive research is being conducted on protein crystallization and crystallography, as they help in the structural determination of proteins. These factors are contributing to the growth of the market in the region.
The market is rapidly advancing through research and development processes, utilizing ELISA sandwich approaches and mass spectrometry to explore protein interactions. Key segments include spectroscopy, chromatography, electrophoresis, protein microarrays, and protein fractionation, each integral in proteomic technologies. Laboratories offer immunoassay reagents to support protein biology research, enhancing protein interaction analysis across proteomic networks. Securing funds is crucial for innovative laboratory services aimed at advancing proteomic capabilities and applications in biotechnology and medicine. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
The emergence of precision proteomics is a major factor driving the market growth. Precision proteomics is a key factor propelling the global proteomics industry. It employs advanced analytical tools to accurately identify and quantify proteins in complex biological samples. This approach enhances our understanding of biological systems and disease mechanisms, enabling the development of targeted therapies. Precision proteomics also facilitates the discovery of disease biomarkers and potential drug targets.
Further, recent advancements in mass spectrometry, bioinformatics, and sample preparation techniques have fueled the growth of precision proteomics. The increasing prevalence of chronic diseases and the demand for personalized treatments further contribute to its adoption. As precision medicine evolves, proteomics will continue to play a crucial role in unravelling disease biology and advancing drug development, ensuring the market's growth in the forecast period.
The emergence of label-free quantification techniques is a major trend in the market. The market has witnessed notable trends, including the rise of label-free quantification techniques. Label-free quantification utilizes mass spectrometry-based methods to measure proteins without chemical or isotopic labels. This approach is gaining popularity due to its advantages, including enhanced accuracy, reproducibility, and cost-effectiveness, as well as the ability to analyze larger sample sizes. Furthermore, label-free quantification avoids potential artifacts caused by labeling interference.
Other trends in the market include the increased use of high-throughput technologies, greater adoption of proteomics in drug discovery, and the integration of proteomics with omics technologies like genomics and metabolomics. The market is anticipated to continue growing as personalized medicine gains demand, proteomics technology advances, and proteomics finds application in diverse fields such as drug discovery, clinical diagnostics, and agricultural research.
Experimental challenges in protein structure determination is a major factor hindering the market growth. One of the major challenges in the market is the experimental difficulties associated with determining protein structures. Protein structure determination is a complex process that often requires multiple techniques and expertise. Current methods, like X-ray crystallography and NMR spectroscopy, have limitations and may not always be successful. Large, multi-domain proteins, membrane proteins, and proteins with flexible regions pose particular challenges. Additionally, detecting post-translational modifications (PTMs) and the cost and time required for protein structure determination are significant obstacles.
These challenges hinder the growth of the proteomics market. Overcoming them necessitates developing new techniques, improving existing methods, and fostering interdisciplinary collaboration. The inherent instability and flexibility of proteins present challenges across various proteomics aspects, impeding the market's progress in the forecast period.
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
Customer Landscape
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments
You may also interested in below market reports:
The market is propelled by advancements such as DNA aptamers and high-throughput analysis, revolutionizing protein research. With a focus on understanding protein-protein interactions and the genetically encoded human proteome, researchers explore therapeutic targets for various genetic disorders and birth disorders. Scalability and data integration enable comprehensive analyses of proteomes, identifying protein abundances, variations, and interacting partners within cellular processes. Cutting-edge informatics tools facilitate multiplexed analysis and data interpretation, enhancing resolution and biomarker discovery. Through network analysis and data analysis, researchers gain insights into complex biological systems, paving the way for novel therapeutic interventions and precision medicine. In this dynamic landscape, the Proteomics Market continues to evolve, driving innovation and transforming our understanding of protein function and disease mechanisms.
Further, understanding kinetics and interactions is vital, driving the demand for polyclonal antibodies and advanced proteomics instruments. Various sample types and species diversity necessitate robust data management solutions for efficient analysis. The proteomics industry witnesses significant investments in research and development, propelled by healthcare expenditure and funding opportunities. Nanotechnology and robotics enhance laboratory efficiency and maintenance, while outsourcing enables access to specialized services. Clinical diagnosis benefits from proteomics technologies like mass spectrometry and electrophoresis, offering insights into protein profiling and interaction analysis. Industry players compete in segments including spectroscopy, chromatography, and protein fractionation, driving innovation and awareness in proteomics research.
Market Scope |
|
Report Coverage |
Details |
Page number |
181 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 16.83% |
Market Growth 2024-2028 |
USD 34.00 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
14.01 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, UK, Germany, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Agilent Technologies Inc., Applied Biomics Inc., Bio Rad Laboratories Inc., Biognosys AG, Bruker Corp., Cell Signaling Technology Inc., CellCarta Biosciences Inc., Creative Proteomics, DiaSorin Spa, F. Hoffmann La Roche Ltd., Geno Technology Inc., HORIBA Ltd., Illumina Inc., Merck KGaA, Olink Holding AB, Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., and Waters Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.